Skip Navigation
  • UC Riverside
  • University Advancement
  • Strategic Communications

Overpromised Cures: Why We Need to Rethink Investments in Medical Care and Biomedical Research

Thursday, May 25, 2017
  11:30 a.m.–1 p.m.


Location: CHASS Interdisciplinary Bldg South 1113
  Parking Information

Category: Seminar

Description:
Healthcare in the United States is the biggest sector in the largest economy in the history of the 

world. This year, we will spend nearly $3.2 trillion on health services. In addition, the United States has the largest biomedical research enterprise in the world with annual federal expenditures approaching $35 billion. Despite these large expenditures, health outcomes in the United States are not exceptional. In contrast to other prosperous economies, life expectancies in the United States have been systematically losing ground over the last 35 years. This presentation uses a variety of data sources to challenge  the narrative that the investments on medical research and medical care are on the right track. The presentation offers detailed analyses of progress in basic biological science, including precision medicine.  It summarizes evidence from the current literature and concludes that we need a shake-up in the dominant paradigm. The analyses also suggest that many public health services may have been under resourced. Both public health and traditional biological models require continuing support. However, the allocation models may need adjustment.  A new allocation model might ultimately lead to better  health for more people without increasing cost. 


Open to: General Public
Admission: Free
Sponsor: One Health Center

Contact Information:
One Health Center
(951) 827-5656
mark.manalang@ucr.edu